October marked the first time this year there was an increase in both the number of biotech and pharma companies trimming ...

During Q3, there was a 31% year-over-year increase in job postings live on BioSpace. The number of employees affected by ...

“Precision Oncology: Changing the Game for Metastatic Liver Cancer” to air Sunday, November 15 at 5:30 p.m. ET / 2:30 pm PT ...

Today the American College of Rheumatology (ACR) announced the appointment of Hospital for Special Surgery (HSS) ...

If approved, detalimogene would be the first and only non-viral plasmid gene therapy suitable for integration into any ...

Juniper Biosciences ("Juniper" or "the Company"), a radiopharmaceutical drug development company, today announced the ...

Cumulative prescribers reached 2,410, exceeding the Company’s original full-year 2026 goal of approximately 2,000 a quarter ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

At the same time, Jason Duncan brings to us a rare combination of legal, governance and operational experience helping scale ...

Wednesday, December 2 at 9:00 a.m. ET Live and archived webcasts of the presentations will be available on the “Events” ...

Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of ...

Nearly three times as many patients taking Taltz and Zepbound achieved ≥50% reduction in psoriatic arthritis disease activity ...